Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU - Gisbert, JP; Donday, MG; Riestra, S; Lucendo, AJ; Benitez, JM; Navarro-Llavat, M; Barrio, J; Morales-Alvarado, VJ; Rivero, M; Busquets, D; Carnerero, EL; Merino, O; et al. (Gut, 2025)